
    
      To demonstrate the non-inferiority in terms of FEV1 AUC0-12h between a single dose of CHF
      1535 via NEXT DPI and CHF 1535 via HFA-134a "extrafine" pMDI in partly controlled adult
      asthmatic patients
    
  